Report Thumbnail
Product Code LP091351046CCV
Published Date 2023/2/28
English117 PagesGlobal

Global Dextromethorphan Hydrobromide Market Growth 2023-2029ConsumerGoods_Retail Market


Report Thumbnail
Product Code LP091351046CCV◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/28
English 117 PagesGlobal

Global Dextromethorphan Hydrobromide Market Growth 2023-2029ConsumerGoods_Retail Market



Abstract


Summary

Dextromethorphan hydrobromide, C18H25NO·HBr·H2O, the formula weight is 370.32, and its form is white crystal powder. LPI (LP Information)' newest research report, the “Dextromethorphan Hydrobromide Industry Forecast” looks at past sales and reviews total world Dextromethorphan Hydrobromide sales in 2022, providing a comprehensive analysis by region and market sector of projected Dextromethorphan Hydrobromide sales for 2023 through 2029. With Dextromethorphan Hydrobromide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextromethorphan Hydrobromide industry. This Insight Report provides a comprehensive analysis of the global Dextromethorphan Hydrobromide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextromethorphan Hydrobromide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dextromethorphan Hydrobromide market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextromethorphan Hydrobromide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextromethorphan Hydrobromide. The global Dextromethorphan Hydrobromide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. Dextromethorphan hydrobromide is used for dry cough, including cough caused by upper respiratory tract infections (such as colds and pharyngitis) and bronchitis. This report presents a comprehensive overview, market shares, and growth opportunities of Dextromethorphan Hydrobromide market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Tablets Oral Solution Segmentation by application Hospital Pharmacies Retail Pharmacies Online Pharmacies This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Sine Pharma United Pharma Baiyunshan Pharma Tianheng Pharma Hanchen Pharma Meiyou Pharma South China Pharma Bayer yililuoding Pharma Wanjie Pharma Kendall Healthcare Major Pharma Euphony Healthcare Mayne Pharma Beximco Pharma West-Coast Key Questions Addressed in this Report What is the 10-year outlook for the global Dextromethorphan Hydrobromide market? What factors are driving Dextromethorphan Hydrobromide market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Dextromethorphan Hydrobromide market opportunities vary by end market size? How does Dextromethorphan Hydrobromide break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Dextromethorphan Hydrobromide Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Dextromethorphan Hydrobromide by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Dextromethorphan Hydrobromide by Country/Region, 2018, 2022 & 2029
    • 2.2 Dextromethorphan Hydrobromide Segment by Type
      • 2.2.1 Tablets
      • 2.2.2 Oral Solution
    • 2.3 Dextromethorphan Hydrobromide Sales by Type
      • 2.3.1 Global Dextromethorphan Hydrobromide Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Dextromethorphan Hydrobromide Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Dextromethorphan Hydrobromide Sale Price by Type (2018-2023)
    • 2.4 Dextromethorphan Hydrobromide Segment by Application
      • 2.4.1 Hospital Pharmacies
      • 2.4.2 Retail Pharmacies
      • 2.4.3 Online Pharmacies
    • 2.5 Dextromethorphan Hydrobromide Sales by Application
      • 2.5.1 Global Dextromethorphan Hydrobromide Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Dextromethorphan Hydrobromide Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Dextromethorphan Hydrobromide Sale Price by Application (2018-2023)
  • 3 Global Dextromethorphan Hydrobromide by Company

    • 3.1 Global Dextromethorphan Hydrobromide Breakdown Data by Company
      • 3.1.1 Global Dextromethorphan Hydrobromide Annual Sales by Company (2018-2023)
      • 3.1.2 Global Dextromethorphan Hydrobromide Sales Market Share by Company (2018-2023)
    • 3.2 Global Dextromethorphan Hydrobromide Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Dextromethorphan Hydrobromide Revenue by Company (2018-2023)
      • 3.2.2 Global Dextromethorphan Hydrobromide Revenue Market Share by Company (2018-2023)
    • 3.3 Global Dextromethorphan Hydrobromide Sale Price by Company
    • 3.4 Key Manufacturers Dextromethorphan Hydrobromide Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Dextromethorphan Hydrobromide Product Location Distribution
      • 3.4.2 Players Dextromethorphan Hydrobromide Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Dextromethorphan Hydrobromide by Geographic Region

    • 4.1 World Historic Dextromethorphan Hydrobromide Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Dextromethorphan Hydrobromide Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Dextromethorphan Hydrobromide Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Dextromethorphan Hydrobromide Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Dextromethorphan Hydrobromide Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Dextromethorphan Hydrobromide Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Dextromethorphan Hydrobromide Sales Growth
    • 4.4 APAC Dextromethorphan Hydrobromide Sales Growth
    • 4.5 Europe Dextromethorphan Hydrobromide Sales Growth
    • 4.6 Middle East & Africa Dextromethorphan Hydrobromide Sales Growth
  • 5 Americas

    • 5.1 Americas Dextromethorphan Hydrobromide Sales by Country
      • 5.1.1 Americas Dextromethorphan Hydrobromide Sales by Country (2018-2023)
      • 5.1.2 Americas Dextromethorphan Hydrobromide Revenue by Country (2018-2023)
    • 5.2 Americas Dextromethorphan Hydrobromide Sales by Type
    • 5.3 Americas Dextromethorphan Hydrobromide Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Dextromethorphan Hydrobromide Sales by Region
      • 6.1.1 APAC Dextromethorphan Hydrobromide Sales by Region (2018-2023)
      • 6.1.2 APAC Dextromethorphan Hydrobromide Revenue by Region (2018-2023)
    • 6.2 APAC Dextromethorphan Hydrobromide Sales by Type
    • 6.3 APAC Dextromethorphan Hydrobromide Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Dextromethorphan Hydrobromide by Country
      • 7.1.1 Europe Dextromethorphan Hydrobromide Sales by Country (2018-2023)
      • 7.1.2 Europe Dextromethorphan Hydrobromide Revenue by Country (2018-2023)
    • 7.2 Europe Dextromethorphan Hydrobromide Sales by Type
    • 7.3 Europe Dextromethorphan Hydrobromide Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Dextromethorphan Hydrobromide by Country
      • 8.1.1 Middle East & Africa Dextromethorphan Hydrobromide Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Dextromethorphan Hydrobromide Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Dextromethorphan Hydrobromide Sales by Type
    • 8.3 Middle East & Africa Dextromethorphan Hydrobromide Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Dextromethorphan Hydrobromide
    • 10.3 Manufacturing Process Analysis of Dextromethorphan Hydrobromide
    • 10.4 Industry Chain Structure of Dextromethorphan Hydrobromide
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Dextromethorphan Hydrobromide Distributors
    • 11.3 Dextromethorphan Hydrobromide Customer
  • 12 World Forecast Review for Dextromethorphan Hydrobromide by Geographic Region

    • 12.1 Global Dextromethorphan Hydrobromide Market Size Forecast by Region
      • 12.1.1 Global Dextromethorphan Hydrobromide Forecast by Region (2024-2029)
      • 12.1.2 Global Dextromethorphan Hydrobromide Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Dextromethorphan Hydrobromide Forecast by Type
    • 12.7 Global Dextromethorphan Hydrobromide Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Sine Pharma
      • 13.1.1 Sine Pharma Company Information
      • 13.1.2 Sine Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.1.3 Sine Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Sine Pharma Main Business Overview
      • 13.1.5 Sine Pharma Latest Developments
    • 13.2 United Pharma
      • 13.2.1 United Pharma Company Information
      • 13.2.2 United Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.2.3 United Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 United Pharma Main Business Overview
      • 13.2.5 United Pharma Latest Developments
    • 13.3 Baiyunshan Pharma
      • 13.3.1 Baiyunshan Pharma Company Information
      • 13.3.2 Baiyunshan Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.3.3 Baiyunshan Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Baiyunshan Pharma Main Business Overview
      • 13.3.5 Baiyunshan Pharma Latest Developments
    • 13.4 Tianheng Pharma
      • 13.4.1 Tianheng Pharma Company Information
      • 13.4.2 Tianheng Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.4.3 Tianheng Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Tianheng Pharma Main Business Overview
      • 13.4.5 Tianheng Pharma Latest Developments
    • 13.5 Hanchen Pharma
      • 13.5.1 Hanchen Pharma Company Information
      • 13.5.2 Hanchen Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.5.3 Hanchen Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Hanchen Pharma Main Business Overview
      • 13.5.5 Hanchen Pharma Latest Developments
    • 13.6 Meiyou Pharma
      • 13.6.1 Meiyou Pharma Company Information
      • 13.6.2 Meiyou Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.6.3 Meiyou Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 Meiyou Pharma Main Business Overview
      • 13.6.5 Meiyou Pharma Latest Developments
    • 13.7 South China Pharma
      • 13.7.1 South China Pharma Company Information
      • 13.7.2 South China Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.7.3 South China Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 South China Pharma Main Business Overview
      • 13.7.5 South China Pharma Latest Developments
    • 13.8 Bayer
      • 13.8.1 Bayer Company Information
      • 13.8.2 Bayer Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.8.3 Bayer Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 Bayer Main Business Overview
      • 13.8.5 Bayer Latest Developments
    • 13.9 yililuoding Pharma
      • 13.9.1 yililuoding Pharma Company Information
      • 13.9.2 yililuoding Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.9.3 yililuoding Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 yililuoding Pharma Main Business Overview
      • 13.9.5 yililuoding Pharma Latest Developments
    • 13.10 Wanjie Pharma
      • 13.10.1 Wanjie Pharma Company Information
      • 13.10.2 Wanjie Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.10.3 Wanjie Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 Wanjie Pharma Main Business Overview
      • 13.10.5 Wanjie Pharma Latest Developments
    • 13.11 Kendall Healthcare
      • 13.11.1 Kendall Healthcare Company Information
      • 13.11.2 Kendall Healthcare Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.11.3 Kendall Healthcare Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 Kendall Healthcare Main Business Overview
      • 13.11.5 Kendall Healthcare Latest Developments
    • 13.12 Major Pharma
      • 13.12.1 Major Pharma Company Information
      • 13.12.2 Major Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.12.3 Major Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.12.4 Major Pharma Main Business Overview
      • 13.12.5 Major Pharma Latest Developments
    • 13.13 Euphony Healthcare
      • 13.13.1 Euphony Healthcare Company Information
      • 13.13.2 Euphony Healthcare Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.13.3 Euphony Healthcare Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.13.4 Euphony Healthcare Main Business Overview
      • 13.13.5 Euphony Healthcare Latest Developments
    • 13.14 Mayne Pharma
      • 13.14.1 Mayne Pharma Company Information
      • 13.14.2 Mayne Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.14.3 Mayne Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.14.4 Mayne Pharma Main Business Overview
      • 13.14.5 Mayne Pharma Latest Developments
    • 13.15 Beximco Pharma
      • 13.15.1 Beximco Pharma Company Information
      • 13.15.2 Beximco Pharma Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.15.3 Beximco Pharma Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.15.4 Beximco Pharma Main Business Overview
      • 13.15.5 Beximco Pharma Latest Developments
    • 13.16 West-Coast
      • 13.16.1 West-Coast Company Information
      • 13.16.2 West-Coast Dextromethorphan Hydrobromide Product Portfolios and Specifications
      • 13.16.3 West-Coast Dextromethorphan Hydrobromide Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.16.4 West-Coast Main Business Overview
      • 13.16.5 West-Coast Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.